用4-羟基苯丙酮酸双加氧酶抑制剂（NTBC）治疗两名患有I型遗传性酪氨酸血症和长期肾病的儿童。 - Suppr

Suppr

超能文献

Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC).

作者信息

Pronicka E, Rowinska E, Bentkowski Z, Zawadzki J, Holme E, Lindstedt S

机构信息

Department of Metabolic Diseases, Children's Memorial Health Institute, Warsaw, Poland.

出版信息

J Inherit Metab Dis. 1996;19(2):234-8. doi: 10.1007/BF01799438.

DOI:10.1007/BF01799438

PMID:8739974

Abstract

摘要

相似文献

Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC).用4-羟基苯丙酮酸双加氧酶抑制剂（NTBC）治疗两名患有I型遗传性酪氨酸血症和长期肾病的儿童。

J Inherit Metab Dis. 1996;19(2):234-8. doi: 10.1007/BF01799438.

Plasma antioxidant capacity in two cases of tyrosinaemia type 1: one case treated with NTBC.两例1型酪氨酸血症患者的血浆抗氧化能力：一例接受NTBC治疗。

J Inherit Metab Dis. 1995;18(2):123-6. doi: 10.1007/BF00711745.

NTBC as palliative treatment in chronic tyrosinaemia type I.NTBC作为1型慢性酪氨酸血症的姑息治疗方法。

J Inherit Metab Dis. 1999 Jun;22(5):665-6. doi: 10.1023/a:1005594416973.

New treatment for tyrosinaemia.酪氨酸血症的新疗法。

Lancet. 1992 Oct 3;340(8823):822-3.

NTBC and alkaptonuria.NTBC与黑尿症

Am J Hum Genet. 1998 Sep;63(3):920-1. doi: 10.1086/302027.

Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.通过抑制4-羟基苯丙酮酸双加氧酶治疗I型遗传性酪氨酸血症。

Lancet. 1992 Oct 3;340(8823):813-7. doi: 10.1016/0140-6736(92)92685-9.

Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).I型酪氨酸血症与NTBC（2-（2-硝基-4-三氟甲基苯甲酰基）-1,3-环己二酮）

J Inherit Metab Dis. 1998 Aug;21(5):507-17. doi: 10.1023/a:1005410820201.

From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug.从毒理学问题到治疗用途：2-(2-硝基-4-三氟甲基苯甲酰基)-1,3-环己二酮（NTBC）作用机制的发现、毒理学及药物研发

J Inherit Metab Dis. 1998 Aug;21(5):498-506. doi: 10.1023/a:1005458703363.

Promising new treatment for type I tyrosinemia.I型酪氨酸血症的前景广阔的新疗法。

J Pediatr Gastroenterol Nutr. 1993 Oct;17(3):340-1.

[Favorable outcome of treatment with NTBC of acute liver insufficiency disclosing hereditary tyrosinemia type I].[应用NTBC治疗暴发性肝功能衰竭伴I型遗传性酪氨酸血症取得良好疗效]

Arch Pediatr. 1999 May;6(5):540-4. doi: 10.1016/s0929-693x(99)80562-4.

引用本文的文献

Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1.1 型酪氨酸血症的药物治疗的长期结果和实际考虑

Paediatr Drugs. 2019 Dec;21(6):413-426. doi: 10.1007/s40272-019-00364-4.

Renal tubular function in children with tyrosinaemia type I treated with nitisinone.用尼替西农治疗的Ⅰ型酪氨酸血症患儿的肾小管功能

J Inherit Metab Dis. 2008 Jun;31(3):399-402. doi: 10.1007/s10545-008-0817-x. Epub 2008 May 23.

New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients.终末期慢性肝病和急性肝衰竭的新管理方案：儿科患者的潜力。

Paediatr Drugs. 2006;8(1):1-13. doi: 10.2165/00148581-200608010-00001.

Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.I型遗传性酪氨酸血症小鼠模型的治疗试验：进展报告。

J Inherit Metab Dis. 1998 Aug;21(5):518-31. doi: 10.1023/a:1005462804271.

Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).I型酪氨酸血症与NTBC（2-（2-硝基-4-三氟甲基苯甲酰基）-1,3-环己二酮）

J Inherit Metab Dis. 1998 Aug;21(5):507-17. doi: 10.1023/a:1005410820201.

本文引用的文献

Renal bicarbonate reabsorption and hydrogen ion excretion in normal infants.正常婴儿的肾碳酸氢盐重吸收和氢离子排泄。

J Clin Invest. 1967 Aug;46(8):1309-17. doi: 10.1172/JCI105623.

Peripheral neuropathy as the presenting feature of tyrosinaemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase.周围神经病变作为Ⅰ型酪氨酸血症的首发特征，并可通过4-羟基苯丙酮酸双加氧酶抑制剂得到有效治疗。

J Neurol Neurosurg Psychiatry. 1993 Oct;56(10):1129-32. doi: 10.1136/jnnp.56.10.1129.

Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment.遗传性I型酪氨酸血症：一种新的临床分类，饮食治疗的预后存在差异。

Hepatology. 1994 Nov;20(5):1187-91.

The nephropathy of type I tyrosinemia after liver transplantation.肝移植后 I 型酪氨酸血症的肾病

Pediatr Res. 1995 May;37(5):640-5. doi: 10.1203/00006450-199505000-00015.

Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.肝外组织对I型遗传性酪氨酸血症生化异常的影响：3例肝移植患者的研究

J Pediatr. 1987 Mar;110(3):399-403. doi: 10.1016/s0022-3476(87)80501-2.

Renal failure in adult patients with hereditary tyrosinaemia type I.成年I型遗传性酪氨酸血症患者的肾衰竭

J Inherit Metab Dis. 1991;14(1):53-62. doi: 10.1007/BF01804389.

Rapid improvement in the renal tubular dysfunction associated with tyrosinemia following hepatic replacement.肝移植后与酪氨酸血症相关的肾小管功能障碍迅速改善。

Pediatrics. 1992 Feb;89(2):251-5.

Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.通过抑制4-羟基苯丙酮酸双加氧酶治疗I型遗传性酪氨酸血症。

Lancet. 1992 Oct 3;340(8823):813-7. doi: 10.1016/0140-6736(92)92685-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验